• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性颅内高压的代谢概念及其治疗干预的潜力。

Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention.

机构信息

Department of Metabolic Neurology (CH, SPM, HB, AJS), Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; Birmingham Neuro-Ophthalmology Unit (SPM, AJS), Ophthalmology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom; Centre for Endocrinology, Diabetes and Metabolism (HB, MWOR, AJS), Birmingham Health Partners, United Kingdom; and Department of Neurology (AJS), University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.

出版信息

J Neuroophthalmol. 2018 Dec;38(4):522-530. doi: 10.1097/WNO.0000000000000684.

DOI:10.1097/WNO.0000000000000684
PMID:29985799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6215484/
Abstract

BACKGROUND

Traditional risk factors associated with idiopathic intracranial hypertension (IIH) include obesity, weight gain, and female sex. The incidence of IIH is increasing and yet the underlying trigger and the fueling pathological mechanisms are still poorly understood.

EVIDENCE ACQUISITION

Review of ophthalmology, neurology, general surgery, obesity, endocrinology, nutrition, and neurosurgery literature was made.

RESULTS

The facts that implicate sex and obesity in IIH and headache are examined. The role of fat distribution in IIH is questioned, and the concept of adipose tissue functioning as an endocrine organ driving IIH is discussed. The impact of androgen metabolism in IIH is reviewed as is the emerging role of glucagon-like-peptide-1 analogues in modulating intracranial pressure. This introduces the concept of developing targeted disease-modifying therapeutic strategies for IIH.

CONCLUSIONS

This review will discuss the possible role of the adipose/gut/brain metabolism axis in IIH and speculate how this may impact the pathogenesis of IIH and therapeutic opportunities.

摘要

背景

与特发性颅内高压(IIH)相关的传统危险因素包括肥胖、体重增加和女性。IIH 的发病率正在增加,但潜在的触发因素和促进病理机制仍知之甚少。

证据获取

对眼科、神经科、普通外科、肥胖、内分泌学、营养学和神经外科文献进行了回顾。

结果

检查了性别和肥胖与 IIH 和头痛的关系。质疑了脂肪分布在 IIH 中的作用,并讨论了脂肪组织作为驱动 IIH 的内分泌器官的概念。审查了雄激素代谢在 IIH 中的作用,以及胰高血糖素样肽-1 类似物在调节颅内压方面的新作用。这引入了为 IIH 开发靶向疾病修正治疗策略的概念。

结论

本综述将讨论脂肪/肠道/大脑代谢轴在 IIH 中的可能作用,并推测这可能如何影响 IIH 的发病机制和治疗机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01e/6257505/0afcedc78920/jno-38-522-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01e/6257505/69493a0518fb/jno-38-522-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01e/6257505/0afcedc78920/jno-38-522-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01e/6257505/69493a0518fb/jno-38-522-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01e/6257505/0afcedc78920/jno-38-522-g003.jpg

相似文献

1
Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention.特发性颅内高压的代谢概念及其治疗干预的潜力。
J Neuroophthalmol. 2018 Dec;38(4):522-530. doi: 10.1097/WNO.0000000000000684.
2
Idiopathic intracranial hypertension: can studies of obesity provide the key to understanding pathogenesis?特发性颅内高压:肥胖研究能否为理解发病机制提供关键线索?
Br J Neurosurg. 2008 Apr;22(2):187-94. doi: 10.1080/02688690701827340.
3
Emerging themes in idiopathic intracranial hypertension.特发性颅内高压的新兴主题。
J Neurol. 2020 Dec;267(12):3776-3784. doi: 10.1007/s00415-020-10090-4. Epub 2020 Jul 22.
4
Obesity and Weight Loss in Idiopathic Intracranial Hypertension: A Narrative Review.特发性颅内高压中的肥胖与体重减轻:一项叙述性综述
J Neuroophthalmol. 2017 Jun;37(2):197-205. doi: 10.1097/WNO.0000000000000448.
5
New horizons for idiopathic intracranial hypertension: advances and challenges.特发性颅内高压的新视野:进展与挑战。
Br Med Bull. 2020 Dec 15;136(1):118-126. doi: 10.1093/bmb/ldaa034.
6
Re-evaluating the Incidence of Idiopathic Intracranial Hypertension in an Era of Increasing Obesity.在肥胖率不断上升的时代重新评估特发性颅内高压的发病率
Ophthalmology. 2017 May;124(5):697-700. doi: 10.1016/j.ophtha.2017.01.006. Epub 2017 Feb 7.
7
Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical Trial.减重手术与社区体重管理干预治疗特发性颅内高压的效果比较:一项随机临床试验。
JAMA Neurol. 2021 Jun 1;78(6):678-686. doi: 10.1001/jamaneurol.2021.0659.
8
The expanding burden of idiopathic intracranial hypertension.特发性颅内高压负担日益加重。
Eye (Lond). 2019 Mar;33(3):478-485. doi: 10.1038/s41433-018-0238-5. Epub 2018 Oct 24.
9
[Treatment of idiopathic intracranial hypertension].[特发性颅内高压的治疗]
Zhonghua Yan Ke Za Zhi. 2016 Dec 11;52(12):948-951. doi: 10.3760/cma.j.issn.0412-4081.2016.12.016.
10
Comparison of bariatric surgery and community weight management for idiopathic intracranial hypertension in a multicenter retrospective cohort study.一项多中心回顾性队列研究中,肥胖症手术与社区体重管理对特发性颅内高压的疗效比较。
Sci Rep. 2025 Apr 22;15(1):13982. doi: 10.1038/s41598-025-97081-5.

引用本文的文献

1
Epidemiological Patterns, Treatment Response, and Metabolic Correlations of Idiopathic Intracranial Hypertension: A United States-Based Study From 1990 to 2024.特发性颅内高压的流行病学模式、治疗反应及代谢相关性:一项基于美国的1990年至2024年的研究
ASIDE Intern Med. 2025 Jan;1(1):31-39. doi: 10.71079/aside.im.0000012282413. Epub 2024 Dec 28.
2
Current Understanding of the Pathophysiology of Idiopathic Intracranial Hypertension.特发性颅内高压病理生理学的当前认识
Curr Neurol Neurosci Rep. 2025 Apr 16;25(1):31. doi: 10.1007/s11910-025-01420-y.
3
Bromocriptine for Idiopathic Intracranial Hypertension: A Retrospective Multicenter Cohort Study.

本文引用的文献

1
Evaluating the Fat Distribution in Idiopathic Intracranial Hypertension Using Dual-Energy X-ray Absorptiometry Scanning.使用双能X线吸收测定扫描评估特发性颅内高压中的脂肪分布。
Neuroophthalmology. 2017 Jun 20;42(2):99-104. doi: 10.1080/01658107.2017.1334218. eCollection 2018 Apr.
2
What Do Transgender Patients Teach Us About Idiopathic Intracranial Hypertension?变性患者能让我们对特发性颅内高压有哪些了解?
Neuroophthalmology. 2017 May 10;41(6):326-329. doi: 10.1080/01658107.2017.1316744. eCollection 2017.
3
Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol.
溴隐亭治疗特发性颅内高压:一项回顾性多中心队列研究。
Int J Gen Med. 2025 Apr 4;18:1933-1943. doi: 10.2147/IJGM.S512250. eCollection 2025.
4
Efficacy of Tirzepatide Dual GIP/GLP-1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real-World Propensity Score-Matched Study.替尔泊肽双重GIP/GLP-1受体激动剂治疗特发性颅内高压患者的疗效。一项真实世界倾向评分匹配研究。
Endocrinol Diabetes Metab. 2025 Mar;8(2):e70019. doi: 10.1002/edm2.70019.
5
Liraglutide for idiopathic intracranial hypertension: a real-world propensity score-matched study.利拉鲁肽治疗特发性颅内高压:一项真实世界倾向评分匹配研究。
Ann Clin Transl Neurol. 2025 Apr;12(4):746-755. doi: 10.1002/acn3.52300. Epub 2025 Feb 13.
6
The Impact of Idiopathic Intracranial Hypertension on Cardiovascular Disease Risk Among UK Women: An Obesity-Adjusted Analysis.特发性颅内高压对英国女性心血管疾病风险的影响:一项肥胖校正分析。
ASIDE Intern Med. 2025 Jan;1(1):1-11. doi: 10.71079/h1fr8h68. Epub 2024 Nov 17.
7
Safety and Efficacy of Metformin for Idiopathic Intracranial Hypertension. A U.S-Based Real-World Data Retrospective Multicenter Cohort Study.二甲双胍治疗特发性颅内高压的安全性和有效性:一项基于美国真实世界数据的回顾性多中心队列研究
ASIDE Intern Med. 2025;1(1):12-19. doi: 10.71079/2024001001. Epub 2024 Dec 28.
8
Epidemiological Patterns, Treatment Response, and Metabolic Correlations of Idiopathic Intracranial Hypertension: A US-Based Study From 1990 to 2024.特发性颅内高压的流行病学模式、治疗反应及代谢相关性:一项基于美国1990年至2024年的研究
medRxiv. 2024 Dec 13:2024.12.08.24318685. doi: 10.1101/2024.12.08.24318685.
9
Cardiometabolic Outcomes in Idiopathic Intracranial Hypertension: An International Matched-Cohort Study.特发性颅内高压的心脏代谢结局:一项国际匹配队列研究
medRxiv. 2024 Nov 13:2024.11.12.24317203. doi: 10.1101/2024.11.12.24317203.
10
Efficacy of Tirzepatide Dual GIP/GLP-1 Receptor Agonist In Patients with Idiopathic Intracranial Hypertension. A Real-World Propensity Score-Matched Study.替尔泊肽双重GIP/GLP-1受体激动剂治疗特发性颅内高压患者的疗效。一项真实世界倾向评分匹配研究。
medRxiv. 2024 Nov 13:2024.11.12.24317193. doi: 10.1101/2024.11.12.24317193.
减肥手术与社区减肥计划对特发性颅内高压持续治疗的随机对照试验:特发性颅内高压体重试验(IIH:WT)方案
BMJ Open. 2017 Sep 27;7(9):e017426. doi: 10.1136/bmjopen-2017-017426.
4
Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial.在特发性颅内高压药物试验IIH:DT中评估11β-羟类固醇脱氢酶1型抑制剂(AZD4017)的疗效和安全性:一项II期随机对照试验的临床方法与设计
JMIR Res Protoc. 2017 Sep 18;6(9):e181. doi: 10.2196/resprot.7806.
5
A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy.Roux-en-Y胃旁路术后胰高血糖素样肽-1的荟萃分析:手术技术和测量策略的影响
Obes Surg. 2018 Mar;28(3):615-626. doi: 10.1007/s11695-017-2913-1.
6
A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus.胰高血糖素样肽-1 受体激动剂可降低脑积水大鼠模型的颅内压。
Sci Transl Med. 2017 Aug 23;9(404). doi: 10.1126/scitranslmed.aan0972.
7
MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease.内分泌学机制:雄激素在人类代谢性疾病中的性别二态性作用
Eur J Endocrinol. 2017 Sep;177(3):R125-R143. doi: 10.1530/EJE-17-0124. Epub 2017 May 31.
8
Re-evaluating the Incidence of Idiopathic Intracranial Hypertension in an Era of Increasing Obesity.在肥胖率不断上升的时代重新评估特发性颅内高压的发病率
Ophthalmology. 2017 May;124(5):697-700. doi: 10.1016/j.ophtha.2017.01.006. Epub 2017 Feb 7.
9
The choroid plexus as a sex hormone target: Functional implications.脉络丛作为一种性激素靶标:功能意义。
Front Neuroendocrinol. 2017 Jan;44:103-121. doi: 10.1016/j.yfrne.2016.12.002. Epub 2016 Dec 18.
10
Obesity and Weight Loss in Idiopathic Intracranial Hypertension: A Narrative Review.特发性颅内高压中的肥胖与体重减轻:一项叙述性综述
J Neuroophthalmol. 2017 Jun;37(2):197-205. doi: 10.1097/WNO.0000000000000448.